July 14,2006

Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs

Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.

Next Article Previous Article

Recent News

10/03/24 CBO Confirms: Biden-Harris Election Year Medicare Cost-Shifting Policy Will Cost Taxpayers Billions in 2025
09/24/24 Crapo Statement at Hearing on Women's Health
09/18/24 Crapo: Idahoans Deserve More Affordable, Accessible Health Care, Not Wasteful Taxpayer-Funded Mandates
09/17/24 Crapo Statement at Hearing on the Inflation Reduction Act’s Health Care Provisions
09/13/24 Crapo: Congress Must Extend 2017 Tax Law